P Devilee

发表

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

P. Devilee, C. Seynaeve, A. Wagner, 2000, The Lancet.

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

C Schafmayer, H Campbell, H Brenner, 2009, British Journal of Cancer.

Somatic genetic changes in human breast cancer.

P. Devilee, C. Cornelisse, C J Cornelisse, 1994, Biochimica et biophysica acta.

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

A. Whittemore, J. Chang-Claude, B. Ponder, 1995, American journal of human genetics.

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

A Hollestelle, J. Martens, A. Sieuwerts, 2014, British Journal of Cancer.

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

B. Devlin, W. Rubinstein, P. Devilee, 2000, Science.

Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.

P L Pearson, J Hermans, P. Devilee, 1991, Oncogene.

Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene

M. J. van de Vijver, J. Peterse, R. Nusse, 1987, Molecular and cellular biology.

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

J Chang-Claude, M. Stratton, J. Chang-Claude, 1998, American journal of human genetics.

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

J. Klijn, P. Devilee, A. Ouweland, 1998, The Lancet.